The rapidly evolving view of lysosomal storage diseases

G Parenti, DL Medina, A Ballabio - EMBO molecular medicine, 2021 - embopress.org
Lysosomal storage diseases are a group of metabolic disorders caused by deficiencies of
several components of lysosomal function. Most commonly affected are lysosomal …

Cutting‐edge LC–MS/MS applications in clinical mass spectrometry: Focusing on analysis of drugs and metabolites

M Maekawa, N Mano - Biomedical Chromatography, 2022 - Wiley Online Library
In recent years, liquid chromatography with tandem mass spectrometry (LC–MS/MS) has
become a fundamental technology in clinical practice. In Japan, the LC–MS/MS system is …

Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers

ECB Eskes, B Sjouke, FM Vaz, SMI Goorden… - Molecular Genetics and …, 2020 - Elsevier
Abstract Acid Sphingomyelinase Deficiency (ASMD), or Niemann-Pick type A/B disease, is a
rare lipid storage disorder leading to accumulation of sphingomyelin and its precursors …

Investigation of diagnostic performance of five urinary cholesterol metabolites for Niemann-Pick disease type C

M Maekawa, I Jinnoh, A Narita, T Iida, D Saigusa… - Journal of Lipid …, 2019 - ASBMB
Niemann-Pick disease type C (NPC) is an autosomal recessive disorder characterized by
progressive nervous degeneration. Because of the diversity of clinical symptoms and onset …

An update on multiplexed mass spectrometry‐based lysosomal storage disease diagnosis

L Darie‐Ion, BA Petre - Mass Spectrometry Reviews, 2024 - Wiley Online Library
Lysosomal storage disorders (LSDs) are a type of inherited metabolic disorders in which
biomolecules, accumulate as a specific substrate in lysosomes due to specific individual …

[HTML][HTML] Development of a highly sensitive and rapid liquid chromatography–tandem mass spectrometric method using a basic mobile phase additive to determine the …

M Maekawa, K Miyoshi, A Narita, T Sato… - Biological and …, 2022 - jstage.jst.go.jp
Abstract As Niemann–Pick disease type C (NPC) is difficult to diagnose owing to its various
clinical symptoms; biomarker tests have been developed. Previously, we revealed urinary …

Metabolomic studies of lipid storage disorders, with special reference to Niemann-Pick type C disease: A critical review with future perspectives

BC Percival, M Gibson, PB Wilson, FM Platt… - International journal of …, 2020 - mdpi.com
Lysosomal storage disorders (LSDs) are predominantly very rare recessive autosomal
neurodegenerative diseases. Sphingolipidoses, a sub-group of LSDs, result from defects in …

Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of Niemann–Pick disease type C

M Maekawa, A Narita, I Jinnoh, T Iida, T Marquardt… - Clinica Chimica …, 2019 - Elsevier
Abstract Background Niemann–Pick disease type C (NPC) is an autosomal recessive
inherited disorder with progressive neuronal degeneration. Because conventional …

Defective cytochrome P450-catalysed drug metabolism in Niemann-Pick type C disease

ER Nicoli, N Al Eisa, CVM Cluzeau, CA Wassif, J Gray… - PLoS …, 2016 - journals.plos.org
Niemann-Pick type C (NPC) disease is a neurodegenerative lysosomal storage disease
caused by mutations in either the NPC1 or NPC2 gene. NPC is characterised by storage of …

Approach of heterogeneous spectrum involving 3beta-hydroxysteroid dehydrogenase 2 deficiency

AG Nicola, M Carsote, AM Gheorghe, E Petrova… - Diagnostics, 2022 - mdpi.com
We aim to review data on 3beta-hydroxysteroid dehydrogenase type II (3βHSD2) deficiency.
We identified 30 studies within the last decade on PubMed: 1 longitudinal study (N= 14), 2 …